EODData

MEMBERSHIP REGISTER LOG IN

FRA, 8E8: ELICERA THERAPEUTICS AB

23 Dec 2025
LAST:

0.4670

CHANGE:
 0.00		OPEN:
0.4670		HIGH:
0.4670		ASK:
0.0000		VOLUME:
250
CHG(%):
0.64		PREV:
0.4700		LOW:
0.4670		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 250.46700.46700.46700.4670250
22 Dec 250.47000.47000.47000.4700250
19 Dec 250.47350.47350.47350.4735250
18 Dec 250.47300.47300.47300.4730250
17 Dec 250.48050.48050.48050.4805250
16 Dec 250.50000.50000.50000.5000250
15 Dec 250.51000.51000.51000.5100250
12 Dec 250.51600.51600.51600.5160250
11 Dec 250.51900.51900.51900.5190250
10 Dec 250.52500.52500.52500.5250250

PROFILE

Name:ELICERA THERAPEUTICS AB
About:Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:World Trade Center Göteborg, Gothenburg, Sweden, 412 51
Website:https://www.elicera.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.06 
PEG Ratio:0.02 
Price to Sales:4.62 
Price to Book:0.88 
Profit Margin:-2.64 
Operating Margin:-1.07 
Return on Assets:-0.28 
Return on Equity:-0.57 
Revenue:546.9K 
Shares:48.54M 
Market Cap:22.67M 

TECHNICAL INDICATORS

MA5:0.471.2%
MA10:0.495.7%
MA20:0.518.4%
MA50:0.519.1%
MA100:0.5212.1%
MA200:0.461.3%
RSI14:13.21 
WPR14:-100.00 
MTM14:-0.10
ROC14:-0.17 
ATR:0.01 
Week High:0.507.1%
Week Low:0.470.0%
Month High:0.5722.9%
Month Low:0.441.3%
Year High:0.6946.7%
Year Low:0.12306.1%
Volatility:47.01